Literature DB >> 33358450

Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models.

Sai P Pydi1, Luiz F Barella1, Jaroslawna Meister1, Jürgen Wess2.   

Abstract

β-Arrestin-1 and -2 are intracellular proteins that are able to inhibit signaling via G protein-coupled receptors (GPCRs). However, both proteins can also modulate cellular functions in a G protein-independent fashion. During the past few years, studies with mutant mice selectivity lacking β-arrestin-1 and/or -2 in metabolically important cell types have led to novel insights into the mechanisms through which β-arrestins regulate key metabolic processes in vivo, including whole-body glucose and energy homeostasis. The novel information gained from these studies should inform the development of novel drugs, including β-arrestin- or G protein-biased GPCR ligands, that could prove useful for the therapy of several important pathophysiological conditions, including type 2 diabetes and obesity. Published by Elsevier Ltd.

Entities:  

Keywords:  G protein-coupled receptors; diabetes; metabolism; mutant mice; obesity; β-arrestins

Mesh:

Substances:

Year:  2020        PMID: 33358450      PMCID: PMC7855863          DOI: 10.1016/j.tem.2020.11.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  89 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 2.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 3.  The many secret lives of adipocytes: implications for diabetes.

Authors:  Philipp E Scherer
Journal:  Diabetologia       Date:  2018-11-21       Impact factor: 10.122

4.  AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue.

Authors:  Sophie M Steculorum; Johan Ruud; Ismene Karakasilioti; Heiko Backes; Linda Engström Ruud; Katharina Timper; Martin E Hess; Eva Tsaousidou; Jan Mauer; Merly C Vogt; Lars Paeger; Stephan Bremser; Andreas C Klein; Donald A Morgan; Peter Frommolt; Paul T Brinkkötter; Philipp Hammerschmidt; Thomas Benzing; Kamal Rahmouni; F Thomas Wunderlich; Peter Kloppenburg; Jens C Brüning
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

5.  Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.

Authors:  Nikhil M Urs; Steven M Gee; Thomas F Pack; John D McCorvy; Tama Evron; Joshua C Snyder; Xiaobao Yang; Ramona M Rodriguiz; Emiliana Borrelli; William C Wetsel; Jian Jin; Bryan L Roth; Patricio O'Donnell; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-01       Impact factor: 11.205

Review 6.  β-arrestins and G protein-coupled receptor trafficking.

Authors:  Xufan Tian; Dong Soo Kang; Jeffrey L Benovic
Journal:  Handb Exp Pharmacol       Date:  2014

7.  Regulation of substrate utilization and adiposity by Agrp neurons.

Authors:  João Paulo Cavalcanti-de-Albuquerque; Jeremy Bober; Marcelo R Zimmer; Marcelo O Dietrich
Journal:  Nat Commun       Date:  2019-01-18       Impact factor: 14.919

8.  Adipocyte β-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis.

Authors:  Sai P Pydi; Shanu Jain; Wesley Tung; Yinghong Cui; Lu Zhu; Wataru Sakamoto; Shalini Jain; Brent S Abel; Monica C Skarulis; Jie Liu; Thanh Huynh; Karel Pacak; Marc G Caron; Oksana Gavrilova; Toren Finkel; Jürgen Wess
Journal:  Nat Commun       Date:  2019-07-03       Impact factor: 14.919

9.  β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility.

Authors:  Jihee Kim; Chad A Grotegut; James W Wisler; Tianyu Li; Lan Mao; Minyong Chen; Wei Chen; Paul B Rosenberg; Howard A Rockman; Robert J Lefkowitz
Journal:  Skelet Muscle       Date:  2018-12-27       Impact factor: 4.912

10.  β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia.

Authors:  Sai P Pydi; Shanu Jain; Luiz F Barella; Lu Zhu; Wataru Sakamoto; Jaroslawna Meister; Lei Wang; Huiyan Lu; Yinghong Cui; Oksana Gavrilova; Jürgen Wess
Journal:  Sci Adv       Date:  2020-06-05       Impact factor: 14.136

View more
  2 in total

Review 1.  Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity.

Authors:  Camila Oliveira de Souza; Xuenan Sun; Dayoung Oh
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555

2.  Designer GPCRs as Novel Tools to Identify Metabolically Important Signaling Pathways.

Authors:  Jürgen Wess
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.